Two labs perform the same experiment. Following identical instructions, they add drugs to cancer cells growing in a Petri dish and wait. In the first lab all the cancer cells die, while in the second the drug has no effect.

The reason for this discrepancy, a study published Wednesday suggests, is that cancer cell lines, regarded by some scientists as genetically uniform, can evolve to have dramatically different responses to drugs.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy